Mr. Andre Jerome reports

BREAKING DOWN BARRIERS: AURORA CANNABIS EASES PATIENT ACCESS TO HIGH QUALITY MEDICAL CANNABIS PRODUCTS IN AUSTRALIA

Aurora Cannabis Inc., in conjunction with MedReleaf Australia, has recently removed the concession card requirement for patients to access medical cannabis products under the company's IndiMed brand. By removing this eligibility barrier, any patient in Australia can be prescribed IndiMed products, providing greater patient access to high-quality medical cannabis options.

"This change to open up patient access to MedReleaf's IndiMed products reflects our dedication to supporting prescribers by creating more seamless and simplified prescribing options," said Andre Jerome, executive vice-president, global business development, at Aurora. "It is a testament to our unmatched expertise in navigating international markets that we have the ability to quickly adapt and apply necessary change with ease, in order to meet patient demand in the rapidly growing medical cannabis market in Australia."

IndiMed was first launched in Australia in 2021 as the very first concession product in the market. Over the years, the IndiMed portfolio has expanded to include oil, additional dried flower product and resin cartridges. Today, IndiMed flower product is consistently ranked in the top-10 most prescribed flowers for cannabis patients.

MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality and consistency, and proudly meets all TGA-GMP standards.

In addition, the company announced it has filed a final short form base shelf prospectus with securities regulators in each of the provinces of Canada, except Quebec, and a corresponding shelf registration statement on Form F-10 with the U.S. Securities and Exchange Commission.

About Aurora Cannabis Inc.

Aurora Cannabis is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora Cannabis is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora Cannabis also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora Cannabis's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora Cannabis's common shares trade on Nasdaq and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.